MARKET

ENOV

ENOV

Enovis Corp
NYSE
42.72
+0.23
+0.54%
Pre Market: 42.80 +0.08 +0.19% 08:00 09/18 EDT
OPEN
42.61
PREV CLOSE
42.49
HIGH
43.29
LOW
42.45
VOLUME
6
TURNOVER
0
52 WEEK HIGH
65.03
52 WEEK LOW
39.98
MARKET CAP
2.39B
P/E (TTM)
-25.8142
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ENOV last week (0909-0913)?
Weekly Report · 2d ago
Enovis Appoints Tim Czartoski as President, U.S. Surgical and Global Product and Enabling Technologies
Barchart · 09/09 14:50
50 stocks that may see selling pressure as investors begin looking to book tax losses
Seeking Alpha · 09/09 14:03
Weekly Report: what happened at ENOV last week (0902-0906)?
Weekly Report · 09/09 09:05
Wells Fargo Remains a Buy on Enovis (ENOV)
TipRanks · 09/09 05:48
Weekly Report: what happened at ENOV last week (0826-0830)?
Weekly Report · 09/02 09:05
Weekly Report: what happened at ENOV last week (0819-0823)?
Weekly Report · 08/26 09:05
Diamond Hill Mid Cap Fund Q2 2024 Market Commentary
Seeking Alpha · 08/22 13:17
More
About ENOV
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment develops, manufactures, and distributes rigid bracing products, orthopedic soft goods, vascular systems and compression garments, and hot and cold therapy products and offers recovery sciences products in the clinical rehabilitation and sports medicine markets, such as bone growth stimulators and electrical stimulators used for pain management. The Reconstructive segment develops, manufactures, and markets a variety of knee, hip, shoulder, elbow, foot, ankle, and finger implant products and surgical productivity tools. It also provides Novastep, a minimally invasive surgery (MIS) foot and ankle solutions.

Webull offers Enovis Corp stock information, including NYSE: ENOV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ENOV stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ENOV stock methods without spending real money on the virtual paper trading platform.